FierceBiotech

LIB's cholesterol-busting drug aces 2nd phase 3 trial, keeping Amgen blockbuster in its sights

LIB Therapeutics has passed another milestone on its path to launching a challenger to cholesterol drugs sold by Amgen, Regeneron and Sanofi. In the latest phase 3 readout, the private biotech’s ...
The Baltimore Sun

Lib’s Grill will open in Sykesville, adding a fourth location for the local restaurant chain

Lib’s Grill, the local restaurant chain with roots in Perry Hall, will add a Carroll County outpost next spring. Owner Nick Liberatore said this week that he has plans to open a fourth location of the ...
The Baltimore Sun

Liberatore’s restaurant to open in Ocean City, and Lib’s Grill in Towson and Sykesville

The popular local family-run restaurant Liberatore’s and its more casual Lib’s Grill spinoff are opening more locations. John Liberatore announced that his namesake restaurant will “finally” be coming ...
Business Wire

LIB Therapeutics Announces Positive Lerodalcibep Results from Two Phase 3 LIBerate Studies at the 92 nd European Atherosclerosis Society Congress

CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep, a novel, once-monthly, LDL-cholesterol lowering, ...